Standout Papers

Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women ... 2009 2026 2014 2020 584
  1. Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study (2009)
    Bella Kaufman, John R. Mackey et al. Journal of Clinical Oncology

Immediate Impact

3 by Nobel laureates 9 from Science/Nature 103 standout
Sub-graph 1 of 21

Citing Papers

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones
2023 Standout
11 intermediate papers

Works of Michaela K. Jahn being referenced

Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
2009 Standout

Author Peers

Author Last Decade Papers Cites
Michaela K. Jahn 187 172 40 521 266 19 951
W. S. Wilcox 128 117 6 296 120 21 1.0k
Richard L. Crownover 199 110 27 189 447 54 966
J.C. Romijn 37 91 181 399 33 997
John A. Engelbach 63 44 143 218 37 1.0k
Valentina Di Gialleonardo 57 17 296 48 17 815
J. Glaholm 78 15 278 337 59 1.2k
L. H. Coutinho 180 205 20 147 87 43 1.0k
Ping‐Chieh Chou 63 22 352 122 22 1.0k
K. Tsuji 13 103 2 420 298 36 1.0k
Moran Grossman 46 91 4 283 34 18 807

All Works

Loading papers...

Rankless by CCL
2026